M by maximally 80 and 90%, respectively. Digital imaging microscopy of cells coloaded with the cytosolic Ca 2ϩ indicator fura-2 revealed that, in parallel, rhod-2 maximally decreased the cytosolic Ca 2ϩ removal rate by 20%. These findings demonstrate that increased mitochondrial ATP production is required for accelerating cytosolic Ca 2ϩ removal during stimulation with a Ca 2ϩ -mobilizing agonist. In contrast, complex I-deficient patient fibroblasts displayed a cytosolic Ca 2ϩ removal rate that was already decreased by 40% compared with healthy fibroblasts. Rhod-2 did not further decrease this rate, indicating the absence of mitochondrial ATP supply to the cytosolic Ca 2ϩ pumps. This work reveals the usefulness of rhodamine-based Ca 2ϩ indicators in examining the role of intramitochondrial Ca 2ϩ in mitochondrial (patho) physiology.
human skin fibroblast; OXPHOS disease; calcium ion extrusion; rhod-2; CGP-37157 MANY AGONISTS ACT UPON RECEPTORS present on the surface of the cell to initiate a cascade of events ultimately resulting in an increase in cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] C ; see Ref. 2) . This increase in [Ca 2ϩ ] C is brought about by inositol 1,4,5-trisphosphate (IP 3 ), a water-soluble messenger that is produced at the plasma membrane from where it rapidly diffuses into the cytosol to open Ca 2ϩ channels present in the endoplasmic reticulum (ER). The latter organelle, which forms the major intracellular Ca 2ϩ store, actively accumulates large amounts of Ca 2ϩ by the action of a Ca 2ϩ pump, the sarcoplasmic/endoplasmic reticulum Ca 2ϩ -ATPase (SERCA). High-speed microscopy has shown that in many cells the agonist-induced increase in [Ca 2ϩ ] C starts in one region and then spreads throughout the whole cell (28, 30) . Initiation of this cytosolic Ca 2ϩ wave occurs at a site where IP 3 channel density is high and/or IP 3 channels are most sensitive to activation by IP 3 . Subsequently, the cytosolic Ca 2ϩ signal propagates by a mechanism referred to as Ca 2ϩ -induced Ca 2ϩ release. Whether or not a global Ca 2ϩ wave arises depends on the Ca 2ϩ concentration that is reached in the initiation region. This, in turn, depends on the number of Ca 2ϩ channels that is opened by IP 3 , which, under the given conditions, depends on the IP 3 concentration and thus on the agonist concentration, the local SERCA activity, and the local concentration of cytosolic Ca 2ϩ buffers. Several studies have shown that the agonist-induced cytosolic Ca 2ϩ signal can be confined to the initiation region by strategically positioned mitochondria (28, 30) . This function of mitochondria critically depends on the potential difference across the inner mitochondrial membrane as was demonstrated by the action of mitochondrial uncouplers and inhibitors of the electron transport chain. Mitochondrial Ca 2ϩ uptake not only controls the local [Ca 2ϩ ] C and, in doing so, the spreading of the cytosolic Ca 2ϩ signal, but also regulates the activity of several enzymes involved in mitochondrial ATP production (5, 8, 11, 12, 25, 26, 32, 33) . In addition, Ca 2ϩ has been postulated to regulate mitochondrial ATP production through a mechanism independent of mitochondrial Ca 2ϩ uptake, involving the activation of the aspartate-malate NADH shuttle by Ca 2ϩ on the external side of the inner mitochondrial membrane (15, 19) . At present, however, the relative importance of this shuttle in agonist-induced mitochondrial ATP production is unclear.
To enhance our understanding of the pathophysiology of disorders of the human oxidative phosphorylation (OXPHOS) system, we study genetically characterized patient skin fibroblasts (13, 14, 27, 32, 33) . In doing so, we recently showed that agonist-induced mitochondrial Ca 2ϩ accumulation and ensuing ATP production are significantly reduced in fibroblasts from patients with a mutation in nuclear encoded subunits of complex I (NADH-ubiquinone oxidoreductase, EC 1.6.5. 
MATERIALS AND METHODS
Chemicals. Culture material was obtained from Invitrogen (Breda, The Netherlands) and fluorescent dyes were from Molecular Probes (Leiden, The Netherlands). Cellfectin, competent DH10bac Escherichia coli cells, and enzymes for DNA cloning were purchased from Invitrogen. All other reagents were from Sigma (St. Louis, MO).
Cell culture. Fibroblasts of two healthy subjects and two patients in whom an isolated complex I deficiency had been confirmed in both muscle tissue and cultured fibroblasts were derived from a skin biopsy after informed parental consent. The patient cells carried a homozygous missense mutation in either the nuclear NDUFS7 gene (G364A; see Ref. 31) or the nuclear NDUFS4 gene (C316T; see Ref. 6 ). Cells were cultured in medium 199 (M199) containing 5 mg/l Tween 20, 10% (vol/vol) FCS, 100 IU/ml penicillin, and 100 IU/ml streptomycin.
Baculovirus-mediated expression of mitochondria-targeted aequorin and luciferase in human skin fibroblasts. The baculovirus expression system, which is normally used for protein production in Spodoptera frugiperda 9 insect cells, was made suitable for protein expression in mammalian cells by first removing the herpes simplex virus thymidine kinase polyadenylation signal from the pFastBacDual vector (Invitrogen) with restriction enzymes AccI and XhoI. Next, the p10-and polyhedron promoter were removed from the vector with SmaI and XbaI and replaced with the coding region of a cytomegalovirus (CMV) promoter digested from the pcDNA1 vector (Invitrogen) with NruI and XbaI. Finally, the cDNA of mitochondria-targeted wild-type aequorin was digested from the AdCMVmAq vector (1) with KpnI and XbaI and ligated behind the CMV promoter in the modified baculovirus transfer vector (BVTVmAq). Similarly, the cDNA of mitochondria-targeted luciferase was digested from the AdCMVmLuc vector (1) with EcoRI and XbaI and ligated in the modified vector (BVTVmLuc). Competent DH10bac E. coli cells, harboring the baculovirus genome (bacmid) and a transposition helper vector, were transformed with BVTVmAq or BVTVmLuc. Recombinant bacmids, formed upon Tn7-mediated site-specific transposition (17) , were isolated and used for transfection of Sf9 insect cells with Cellfectin. After 3 days, recombinant baculoviruses were harvested and used to infect Sf9 cells at a multiplicity of infection of 0.1. After infection (4 days), the amplified viruses were harvested. To express mitochondria-targeted aequorin or luciferase in human skin fibroblasts, ϳ20,000 cells were seeded on a glass cover slip (ϳ14 mm) and cultured for 4 h. 10 HEPES, and 1 CaCl2, pH 7.4). Aequorin luminescence was monitored continuously using a custom-built setup that consisted of a light-shielded low-noise photomultiplier tube (PMT) with a built-in H7360 -1 amplifier-discriminator (Hamamatsu Photonics, Shizuoka-Ken, Japan). PMT output was monitored in time using a PCI-6601 photon counting board (National Instruments, Austin, TX) coupled to an IBM-compatible computer using customwritten software (Drs. S. P. Srinivas and W. van Driessche, Laboratory of Physiology, K. U. Leuven, Leuven, Belgium). Light output was integrated during 1 s. At the end of each measurement, signals were calibrated by lysing the cells with 100 M digitonin in the presence of 10 mM CaCl 2 to determine the total aequorin pool. Aequorin photon emission was converted off-line into [Ca 2ϩ ]M values, using a computer algorithm described previously (4) . To monitor luciferase luminescence with the same system, cells were perfused with HEPES-Tris medium containing 5 M beetle luciferin (Promega) at 37°C. Light output was recorded at 2-s intervals after which the traces were smoothed off-line using a three-point moving average (OriginPro 6.1; OriginLab, Northampton, MA). Typically, light output from a cover slip of fibroblasts expressing mitochondrial luciferase was 500 -1,500 counts/s with a background of 15 counts/s. ]M, fibroblasts, seeded on a glass cover slip (ϳ24 mm), were coloaded with 3 M fura-2 AM and 5 M rhod-2 AM, rhod-5F AM, or rhod-FF AM in serum-free M199 for 25 min at 37°C. After loading, cells were washed two times and allowed to equilibrate for another 10 min. Next, cover slips were mounted in a temperature-controlled (37°C) superfusion chamber attached to the stage of an inverted microscope (Axiovert 200 M; Zeiss, Jena, Germany) equipped with a ϫ63, 1.25 numeric aperture (NA) Plan NeoFluar objective. The fura-2 and rhodamine dyes were excited at 380 and 540 nm, respectively, using a monochromator (Polychrome IV; TILL Photonics, Gräfelfing, Germany). Fluorescence emission light was directed by a 560DRLP dichroic mirror (Omega Optical, Brattleboro, VT) through a 565ALP emission filter (Omega) on a CoolSNAP HQ monochrome chargecoupled device (CCD) camera (Roper Scientific, Vianen, The Netherlands). The camera exposure time was set at 200 ms with an interframe interval of 4 s. For ratiometric measurement of [Ca 2ϩ ]C, fibroblasts loaded with fura-2 were alternately excited at 340 and 380 nm via a ϫ40, 1.3 NA F Fluar objective. Fluorescence emission light was directed by a 415 DCLP dichroic mirror (Omega) through a 510WB40 emission filter (Omega) on the CCD camera (camera exposure time of 200 ms and interframe interval of 1 s). At the end of each measurement, cells were scraped off the cover slip to correct for background fluorescence. The kinetics with which the fluorescence emission ratio (R) returned to basal levels was fitted to a monoexponential equation: R(t) ϭ R(t ϭ 0) ϫ e Ϫ/t ϩ R(P), where is the time constant (in s) and R(P) is the poststimulatory level to which R declines. From the half-time (t 1 ⁄2) was calculated using the equation: t 1 ⁄2(s) ϭ Ϫln(0.5) ⅐ . All hardware was controlled with Metafluor 6.0 software (Universal Imaging, Downingtown, PA).
Digital imaging microscopy of cellular NADH levels. For NADH measurements, cover slips were mounted in the temperature-controlled (37°C) superfusion chamber of the Axiovert 200 M inverted microscope. Cells were excited at 360 nm, and fluorescence emission light was directed by a 415 DCLP dichroic mirror (Omega) through a 480AF30 emission filter (Omega) on the CCD camera (camera exposure time of 1,000 ms and interframe interval of 4 s).
Data analysis. Numerical data were visualized using Origin Pro 6.1 (OriginLab), and values from multiple experiments were expressed as averages Ϯ SE. Statistical significances were assessed by Student's t-test.
RESULTS

Changes in mitochondrial and nuclear Ca
2ϩ concentration reported by the rhodamine-based fluorescent Ca 2ϩ indicator rhod-2. Rhodamine-based fluorescent Ca 2ϩ indicators such as rhod-2, rhod-5F, and rhod-FF have a net positive charge and therefore readily sequestrate in the mitochondrial matrix (20) . With the final aim of using these indicators as intramitochondrial Ca 2ϩ buffers to assess the relationship between Ca 2ϩ -stimulated mitochondrial ATP production and rate of cytosolic Ca 2ϩ removal, we first evaluated their properties in our cell of interest, the human skin fibroblast. Fibroblasts obtained from a healthy control subject (C1; see Ref. 33) were loaded with 5 M rhod-2 AM for 25 min at 37°C and subsequently subjected to digital imaging microscopy. In the absence of any stimulus, the cells showed only faint background fluorescence (Fig. 1A , left). At 60 s, cells were stimulated with a maximal concentration of 1 M Bk. The second left image, taken at 4 s after the onset of stimulation, shows the rapid appearance of fluorescent tubules. The same tubular staining pattern was observed with rhod-5F and rhod-FF. Control experiments employing mitochondria targeted EYFP (COX-EYFP), introduced in these cells by means of the baculovirus expression system, confirmed the mitochondrial nature of these tubules (data not shown).
To monitor the effect of Bk on the free [Ca 2ϩ ] M , we analyzed the change in rhod-2 fluorescence in randomly chosen individual mitochondrial structures in at least two different cells (Fig. 1A) . For comparison, the cells were coloaded with the cytosolic Ca 2ϩ indicator fura-2. When [Ca 2ϩ ] C increases, . For kinetic analysis, the fluorescence emission signal was normalized to its prestimulatory value. C: fibroblasts expressing mitochondria-targeted wild-type aequorin and reconstituted with native coelenterazine were used for luminescence monitoring of the BK-induced [Ca 2ϩ ] changes in the mitochondrial matrix. For comparison, the nuclear fura-2 signal measured in fibroblasts that neither expressed aequorin nor were treated with rhod-2 is shown. The no. of cells and mitochondria analyzed for each condition are given in the text. the latter indicator displays a decrease in fluorescence signal after excitation at 380 nm. The traces depicted in Fig. 1B show that Bk evoked an instantaneous change in both cytosolic (fura-2) and mitochondrial (rhod-2) fluorescence. The rhod-2 signal peaked only few seconds after the fura-2 signal, which reached its highest point at ϳ20 s after the onset of stimulation. The maximum increase in rhod-2 fluorescence was 5.7 Ϯ 0.4 times the prestimulatory value (n ϭ 10 mitochondria in 2 cells). Thereafter, the rhod-2 signal more gradually decreased again to prestimulatory levels reached at 450 s and more after addition of Bk. This decrease was fitted monoexponentially with a t 1 ⁄2 of 78 Ϯ 7 s (n ϭ 10 mitochondria in 2 cells), suggesting the involvement of one major Ca 2ϩ removal process.
The inhibitor of mitochondrial Na ϩ /Ca 2ϩ exchange, CGP-37157 (1 M, 2 min), did not alter the amplitude of the rhod-2 signal (5.6 Ϯ 0.3 times the prestimulatory value, n ϭ 18 mitochondria in 4 untreated cells vs. 5.9 Ϯ 0.2 times the prestimulatory value, n ϭ 24 mitochondria in 5 CGP-37157-treated cells). However, the inhibitor significantly reduced the rate of fluorescence decrease (t 1 ⁄2 of 74 Ϯ 5 s, n ϭ 18 mitochondria in 4 untreated cells vs. 101 Ϯ 7 s, n ϭ 24 mitochondria in 5 CGP-37157-treated cells; P Ͻ 0.01).
Rhod-2 did not reside exclusively in the mitochondrial matrix as was indicated by a simultaneous increase in fluorescence in the nucleoplasm (Fig. 1A) . The nucleoplasm does not contain mitochondrial structures and, because measurements with fura-2 showed no kinetic differences between the nuclear and cytosolic signal, this compartment was chosen to evaluate the cytosolic properties of rhod-2. Figure 1B shows in contrast to the mitochondrial rhod-2 signal that in the nucleoplasm rhod-2 mirrored the fura-2 signal in this compartment to reach prestimulatory levels already at ϳ120 s after addition of Bk.
Changes in [Ca 2ϩ ] M reported by mitochondria targeted wild-type aequorin. We previously showed that Bk (1 M) evoked a rapid increase in luminescence in human skin fibroblasts expressing mitochondria-targeted wild-type aequorin (32, 33) . Figure 1C shows that Bk virtually instantaneously increased [Ca 2ϩ ] M to reach a maximum of 4.6 Ϯ 0.4 M (n ϭ 7 cover slips) after which it rapidly declined again to prestimulatory levels (t 1 ⁄2 of 6.2 Ϯ 0.3 s; n ϭ 7 coverslips). The duration of the mitochondrial aequorin signal was ϳ50 s, which was considerably shorter than that of the signal obtained with rhod-2 (450 s and more). CGP-37157 (1 M, 2 min) did not alter the peak Ca 2ϩ concentration increase in this compartment (4.4 Ϯ 0.1 M, n ϭ 5 coverslips). However, whereas the inhibitor markedly slowed down the decrease in rhod-2 fluorescence, it only slightly affected the decrease in aequorin luminescence (t 1 ⁄2 of 8.1 Ϯ 0.3 s, n ϭ 6 coverslips; P Ͻ 0.05). Most probably, the relatively fast decline of the mitochondrial aequorin signal reflects rapid exhaustion of the Ca 2ϩ -sensitive aequorin-coelenterazine complex. When Bk was applied to cells pretreated with the protonophore carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP; 1 M, 2 min), no change in luminescence signal was observed (data not shown), thus demonstrating the mitochondrial localization of the photoprotein (21 ] M . Figure  2A shows that rhod-2 markedly lowered the amplitude of the Bk-induced increase in [Ca 2ϩ ] M . Similarly, rhod-FF (5 M) decreased this amplitude to 2.5 Ϯ 0.1 M (n ϭ 6 coverslips, P Ͻ 0.01).
The effect of rhod-2 was dose dependent, and half-maximal and maximal (80%) reduction of the Bk-induced peak increase in [Ca 2ϩ ] M was obtained with 3 and 30 M rhod-2 AM, respectively (Fig. 2B) . As a control, we determined the effect of the rhodamine-based indicator for the mitochondrial membrane potential, tetramethylrhodamine methyl ester perchlorate (TMRM Figure 2C shows that Bk significantly increased the luminescence signal only after a lag time of ϳ22 s. The rhod-2 markedly reduced the amplitude of the Bk-induced increase in [ATP] M without altering, however, its onset and/or duration. The same result was obtained in a single experiment testing two concentrations of rhod-FF (data not shown).
Rhod-2 dose dependently lowered the Bk-induced peak increase in luciferase luminescence, and half-maximal and maximal (90%) reduction was achieved with 3 and 30 M rhod-2 AM, respectively (Fig. 2D) (11) . Figure 2E shows that healthy fibroblasts (C1; see Ref. 33 ) responded with a marked increase in NADH fluorescence after a lag time of ϳ12 s after the addition of Bk (1 M). Pretreatment with rhod-2 AM (30 M, 25 min) abolished the Bk-induced increase in NADH. Of note, rhod-2 did not affect the prestimulatory NADH signal. After background correction, gray values obtained with untreated and rhod-2-treated cells were 41 Ϯ 3 (n ϭ 9 cells) and 38 Ϯ 2 (n ϭ 9 cells), respectively.
Taken together, the above data show that Bk (1 M) ] M and [ATP] M in skin fibroblasts of a patient with a decreased activity of the first complex (complex I) of the electron transport chain without altering these responses in fibroblasts of a healthy control subject (32). Here we show that this drug failed to normalize these two parameters in healthy fibroblasts loaded with 5 M rhod-2 (Fig. 3, A and B) . This finding is consistent with rhod-2 acting as a Ca 2ϩ buffer in the mitochondrial matrix. Figure 4A shows that rhod-2 (5 M) significantly further reduced the (Fig. 4B) .
Effects of rhod-2 on the Bk-induced increases in [Ca
Rhod-2 decreases the rate of cytosolic Ca 2ϩ removal in healthy fibroblasts but not in complex I-deficient patient fibroblasts. We showed before that the rate of cytosolic Ca ] C in C1 fibroblasts. On the other hand, the dye significantly slowed down the rate of [Ca 2ϩ ] C decrease in these cells. In each experiment, both the amplitude of the Bk-induced increase in [Ca 2ϩ ] C and the rate at which Ca 2ϩ was subsequently removed from the cytosolic compartment in C1 cells was set at 100%, to which all other values were related.
Neither the amplitude of the Bk-induced increase in [Ca 2ϩ ] C nor the rate at which Ca 2ϩ was subsequently removed from the cytosolic compartment differed between C1 and C3 fibroblasts (Table 1) . Rhod-2 (5 M) did not alter the amplitude of the Bk-induced increase in [Ca 2ϩ ] C in these healthy control cells. Importantly, the lack of effect of a relatively high concentration of rhod-2 (30 M) on this parameter demonstrates that the dye did not act as a Ca 2ϩ buffer in the cytosolic compartment. In C1 cells, the maximal effect of rhod-2 on the rate of cytosolic Ca 2ϩ removal was already obtained after treatment with 5 M rhod-2 AM. Also in C3 cells this treatment caused a significant decrease in cytosolic Ca 2ϩ removal rate. As reported before (32), CGP-37157 (1 M, 2 min) neither changed the peak increase in [Ca 2ϩ ] C nor the cytosolic Ca 2ϩ removal rate in healthy fibroblasts. Here we show that CGP-37157 failed to reverse the inhibitory effect of rhod-2 (5 M) on the rate of cytosolic Ca 2ϩ removal in these cells. Both the amplitude of the Bk-induced increase in [Ca 2ϩ ] C and the rate of cytosolic Ca 2ϩ removal were significantly reduced in patient fibroblasts (Table 1) . In P11 cells, neither 5 nor 30 M rhod-2 caused any further reduction of these two parameters. The same observation was reached with 5 M rhod-2 in P9 fibroblasts. CGP-37157 (1 M, 2 min) normalized both the Bk-induced increase in [Ca 2ϩ ] C and the rate of cytosolic Ca 2ϩ removal in patient fibroblasts. Rhod-2 did not prevent restoration of the Bk-induced increase in [Ca 2ϩ ] C by CGP-37157 in these cells. On the other hand, it abolished normalization of the rate of cytosolic Ca 2ϩ removal by this drug.
DISCUSSION
The data presented in this study demonstrate that cytosolic Ca 2ϩ removal is significantly accelerated as a consequence of increased mitochondrial ATP production in cells stimulated with a Ca 2ϩ -mobilizing agonist. Evidence comes from the observation that both processes were markedly reduced in human skin fibroblasts of healthy subjects loaded with the rhodamine-based fluorescent Ca 2ϩ indicator rhod-2. Because of its positive charge, this indicator readily sequestrated in the mitochondrial matrix, where it reduced the Bk-induced increase in Ca 2ϩ and ATP concentration in a dose-dependent manner. Of crucial importance, fura-2 measurements revealed that, even at a relatively high concentration of 30 M, rhod-2 did not alter the Bk-induced increase in [Ca 2ϩ ] C , demonstrating that the dye did not act as a Ca 2ϩ buffer in the cytosolic compartment. Taken together, the present findings are compatible with the idea that Bk virtually instantaneously increases [Ca 2ϩ ] C and, as a consequence, [Ca 2ϩ ] M to boost the production of NADH (after a lag time of ϳ12 s) and subsequently ATP (after a lag time of ϳ22 s), which is then released in the cytosol, where it accelerates the Ca 2ϩ removal process. In the absence of external Ca 2ϩ , the complex I-deficient patient fibroblasts used in this study displayed a cytosolic Ca 2ϩ removal rate that was ϳ40% lower than that of healthy fibroblasts (Table 1) . Of note, these patient fibroblasts consistently showed an ϳ60% reduction in cytosolic Ca 2ϩ removal rate when stimulated in the presence of external Ca 2ϩ (32, 33) . This extent of reduction in Ca 2ϩ removal rate was found to be paralleled by a 50% decrease in Bk-stimulated mitochondrial ATP production (32, 33) . -stimulated increase in [ATP] M exceeds 50 -60% of its maximum. Notably, the lack of effect of rhod-2 on the rate of cytosolic Ca 2ϩ removal in patient fibroblasts demonstrates that the dye does not interfere with this process other than by inhibiting Ca 2ϩ -stimulated mitochondrial ATP production. The reduced rate of cytosolic Ca 2ϩ removal observed in patient fibroblasts was completely restored upon normalization of the Ca 2ϩ -stimulated increase in mitochondrial ATP production by CGP-37157, an inhibitor of mitochondrial Na ϩ /Ca 2ϩ exchange (5, 16, 32) . This finding demonstrates that the decrease in Ca 2ϩ removal rate observed in complex I-deficient patient fibroblasts is the result of a reduced ATP supply to the cytosolic Ca 2ϩ pumps rather than a pathological decrease in their amount and/or change in geometry of the Ca 2ϩ -handling added and 0.5 mM EGTA present). The rhod-2 slowed down the rate of cytosolic Ca 2ϩ removal but had no effect on the peak Ca 2ϩ concentration increase in this compartment (2 representative traces). compartments. The fact that patient fibroblasts displayed a cytosolic Ca 2ϩ removal rate that was markedly (20%) lower than that of healthy fibroblasts treated with either rhod-2 (this study) or FCCP (32) may then suggest that ATP supply from sources other than the mitochondria is decreased in patient fibroblasts. It remains to be established whether this involves a pathological decrease in glycolytic activity and/or increase in ATP consumption.
The patients used in this study have been described extensively with respect to clinical presentation, disease course, and results of laboratory studies (6, 31) . In both cases, the clinical course was progressive, with first signs of the disease appearing at 4 mo (P9; see Ref. 6 ) and 11 mo (P11; see Ref. 31 ) after birth. The children suffered from severe multisystem defects, and death occurred at 8 mo and 5 yr of age, respectively. Extrapolation of our experimental data to the clinical setting suggests that tissues and organs that have high energy demands encounter severe problems with maintaining energy supply, especially under working conditions, and are therefore vulnerable to a gradual loss of integrity. The two patient cell lines investigated here showed major differences in Bk-stimulated mitochondrial ATP production (33) and cytosolic Ca 2ϩ removal rate (Ref. 33 and this study), indicating that the speed of disease progression depends on multiple factors. This is stressed by our finding that 4 out of 14 complex I-deficient patient cell lines displayed a normal Bk-stimulated increase in [ATP] M (33) .
The inability of CGP-37157 to normalize the increase in [Ca 2ϩ ] M in rhod-2-treated healthy fibroblasts is illustrative of the buffering capacity of this mitochondrial Ca 2ϩ indicator. However, whereas CGP-37157 failed to restore the Ca 2ϩ removal rate in rhod-2-treated patient cells, it fully normalized the peak [Ca 2ϩ ] C increase in these cells. We previously showed that CGP-37157 (1 M, 2 min) does not increase the ER Ca 2ϩ content in these patient cells (32) , thus disfavoring this explanation for the observed normalization of the peak [Ca 2ϩ ] C increase. Another possibility is that CGP-37157 caused saturation of the capacity of the mitochondria to sequester Ca 2ϩ . This was demonstrated for the human umbilical vein endothelial cell line EA.hy926 (18) . However, the present finding that rhod-2, despite its buffering capacity, did not prevent normalization of the peak [Ca 2ϩ ] C increase by CGP-37157 argues against this possibility. Finally, the fact that rhod-2 alone did not augment the peak [Ca 2ϩ ] C increase in these patient fibroblasts argues against a mechanism involving increased mitochondrial Ca 2ϩ uptake. Therefore, CGP-37157 may somehow promote the process of IP 3 -stimulated Ca 2ϩ release from the ER.
We previously showed that the Bk-induced increase in [Ca 2ϩ ] C was significantly reduced in complex I-deficient patient fibroblasts (32, 33) . As mentioned already, this decrease was found to be paralleled by a decrease in ER Ca 2ϩ content. This finding is in agreement with the above conclusion that ATP supply to cytosolic Ca 2ϩ pumps such as the SERCA is reduced in patient fibroblasts. The present study shows that rhod-2 treatment did not affect the Bk-induced increase in [Ca 2ϩ ] M , which not only boosts ATP production but also triggers ADP/ ATP exchange. According to this model, rhod-2 will inhibit both the Ca 2ϩ -induced production and export of ATP. Alternatively, the finding that Bk evokes a relatively small (30%) increase in average mitochondrial ATP signal may suggest that Ca -induced production of ATP in these mitochondria, while leaving the ATP levels in agonist-insensitive mitochondria intact.
Evidence has been provided that Ca 2ϩ on the external side of the inner mitochondrial membrane can regulate mitochondrial ATP production by activating the aspartate-malate NADH shuttle (15, 19) . Thus far, however, the role of Ca 2ϩ in agonist-stimulated mitochondrial ATP production has been addressed solely through manipulation of the agonist-induced increase in [Ca 2ϩ ] C (12) . Obviously, this maneuver does not provide information on the relative importance of the Ca 2ϩ -stimulated aspartate-malate NADH shuttle. The present finding that rhod-2 abolished the Bk-induced increases in NADH (completely) and [ATP] M (virtually completely) without altering the Bk-induced increase in extramitochondrial [Ca 2ϩ ] demonstrates that the aspartate-malate NADH shuttle, if activated, requires an additional increase in intramitochondrial [Ca 2ϩ ] to contribute to agonist-stimulated mitochondrial ATP production in human skin fibroblasts.
Bk readily increased the rhod-2 fluorescence emission intensity in individual mitochondria loaded with 30 M rhod-2 AM (data not shown). This indicates that high concentrations of rhod-2 do not interfere with Ca 2ϩ -stimulated mitochondrial ATP production through inhibition of the mitochondrial Ca 2ϩ entry pathway. The specificity of rhod-2 was demonstrated by the fact that the rhodamine-based mitochondrial membrane potential indicator TMRM maximally reduced the amplitude of the Bk-induced increase in matrix Ca 2ϩ concentration by only 20% and had no effect on the Bk-induced increase in mitochondrial ATP production. The latter observation is consistent with the finding in HeLa cells that inhibition of histaminestimulated mitochondrial ATP production occurred only when the amplitude of the agonist-induced increase in matrix Ca 2ϩ concentration was reduced by Ͼ20% (12) . Similarly, cells treated with 30 M rhodamine 123 displayed a normal increase in mitochondrial ATP production after stimulation with Bk.
Finally, the data presented show that rhod-2 half-maximally inhibited the Bk-induced increases in [Ca 2ϩ ] M and [ATP] M in cells loaded with ϳ3 M rhod-2 AM for 25 min at 37°C. Because most studies use similar loading conditions (3, 6, 9, 11, 25, 29) , results should be regarded with care. 
